BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37855064)

  • 21. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
    Costa JR; Mansour MR
    Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
    [No Abstract]   [Full Text] [Related]  

  • 22. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
    Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
    Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
    Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
    J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
    Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
    Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
    Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
    Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
    Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
    Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
    Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
    Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
    Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
    Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
    Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
    O'Connor KW; Kishimoto K; Kuzma IO; Wagner KP; Selway JS; Roderick JE; Karna KK; Gallagher KM; Hu K; Liu H; Li R; Brehm MA; Zhu LJ; Curtis DJ; Tremblay CS; Kelliher MA
    Leukemia; 2024 May; 38(5):951-962. PubMed ID: 38553571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).
    Nagel S; Ehrentraut S; Tomasch J; Lienenklaus S; Schneider B; Geffers R; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    PLoS One; 2012; 7(7):e40747. PubMed ID: 22848398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
    Jenkins CE; Gusscott S; Wong RJ; Shevchuk OO; Rana G; Giambra V; Tyshchenko K; Islam R; Hirst M; Weng AP
    Exp Hematol; 2018 Aug; 64():84-96. PubMed ID: 29733873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
    Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
    Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
    Ono Y; Fukuhara N; Yoshie O
    J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
    Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
    Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.